Skip to content

Angina Prevalence and Provider Evaluation of Angina Relief

Angina Prevalence and Provider Evaluation of Angina Relief

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01705054
Acronym
APPEAR
Enrollment
1246
Registered
2012-10-12
Start date
2013-07-31
Completion date
2015-07-22
Last updated
2021-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Coronary Artery Disease CAD

Keywords

Angina, Stable ischemic heart disease, Quality of Life, Seattle Angina Questionnaire (SAQ)

Brief summary

The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.

Detailed description

The primary goals in the management of stable coronary artery disease (CAD) are to reduce risk factors for heart attack and to control the symptoms of angina (chest pain). Ideally angina is well controlled with medications alone, but invasive procedures are a valuable option for patients with persistent angina. The amount of angina among patients with stable CAD in the outpatient setting, however, is unknown. An Australian study reported that almost 1 in 3 patients with stable angina being treated by primary care doctors had angina at least once a week, which was associated with worse quality of life. We propose to examine the burden of angina in outpatients with stable CAD who are being medically managed by cardiologists in the United States through administration of a one-time survey. The information from this study could ultimately help improve management of stable CAD and angina and illuminate potential underuse of revascularization. While cardiologists are generally expected to provide better angina control than primary care doctors, establishing the prevalence of angina among the best providers will help with a framework for interpreting symptom control among other practitioners.

Interventions

None listed

Sponsors

Gilead Sciences
CollaboratorINDUSTRY
Saint Luke's Health System
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Coronary artery disease patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.

Exclusion criteria

* Too ill to take survey * Previously completed this survey * Refused to participate

Design outcomes

Primary

MeasureTime frameDescription
Seattle Angina QuestionnaireOne time cardiology office visit.Percentage of patients with frequent angina (\>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).

Secondary

MeasureTime frameDescription
Quality of LifeOne time cardiology office visit.Evaluate the impact of frequent angina on Quality of Life (as measured by the SAQ)
Physician PerspectiveOne time cardiology office visit.Identifying differences between patients' and cardiologists' assessment of angina control
Cardiology practices angina control.One time cardiology office visit.Evaluate the differences in angina control between cardiology practices.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026